Race-associated biological differences among Luminal A breast tumors
- 25 June 2015
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 152 (2) , 437-448
Abstract
African-American (AA) women have higher breast cancer-specific mortality rates. A higher prevalence of the worse outcome Basal-like breast cancer subtype contributes to this, but AA women also have higher mortality even within the more favorable outcome Luminal A breast cancers. These differences may reflect treatment or health care access issues, inherent biological differences, or both. To identify potential biological differences by race among Luminal A breast cancers, gene expression data from 108 CAU and 57 AA breast tumors were analyzed. Race-associated genes were evaluated for associations with survival. Finally, expression of race- and survival-associated genes was evaluated in normal tissue of AA and CAU women. Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR 1.25). For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1). A score based on all six genes predicted survival in a large independent dataset (HR = 1.9 top vs. bottom quartile, 95 % CI: 1.4–2.5). For four genes, normal tissue of AA and CAU women showed similar expression (ACOX2, MUC1, SQLE, TYMS); however, the poor outcome-associated genes CRYBB2 and PSPH were more highly expressed in AA versus CAU women’s normal tissue. This analysis identified gene expression differences that may contribute to mortality disparities and suggests that among Luminal A breast tumors there are biological differences between AA and CAU patients. Some of these differences (CRYBB2 and PSPH) may exist from the earliest stages of tumor development, or may even precede malignancy.Keywords
Funding Information
- National Institutes of Health (5 R25 CA057726-23, R21 CA175783, U01 CA 179715, U01 ES 019472, P50 CA058223, R21 CA175783, U54 CA156735, U54 CA156735, K01CA172717)
This publication has 40 references indexed in Scilit:
- Racial disparities in initiation of adjuvant endocrine therapy of early breast cancerBreast Cancer Research and Treatment, 2014
- Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decisionBMC Gastroenterology, 2013
- Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancerBMC Research Notes, 2012
- Identification of differentially expressed genes in breast tumors from African American compared with Caucasian womenCancer, 2011
- Mutation screen of β-crystallin genes in 274 patients with age-related macular degenerationOphthalmic Genetics, 2010
- Comprehensive gene expression analysis of 5′-end of mRNA identified novel intronic transcripts associated with hepatocellular carcinomaGenomics, 2010
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- MUC1 is a Promising Therapeutic Target for Prostate Cancer TherapyCurrent Cancer Drug Targets, 2007
- Molecular profiling of endometrial cancers from African–American and Caucasian womenGynecologic Oncology, 2006
- Open source clustering softwareBioinformatics, 2004